Home > Healthcare > Pharmaceuticals > Finished Drug Form > Pain Relief Patches Market

Pain Relief Patches Market Size - By Type (Prescription Patches, Over-the-counter Patches), Application (Muscle Pain, Joint Pain, Sports Injuries, Back Pain, Minor aches and pains), Pack Size, Price Range, End-use, Distribution Channel & Forecast, 2024 - 2032

  • Report ID: GMI10077
  • Published Date: Jul 2024
  • Report Format: PDF

Pain Relief Patches Market Size

Pain Relief Patches Market size was valued at USD 3.9 billion in 2023 and is estimated to grow at a CAGR of 6.2% between 2024 and 2032. The global population is aging, leading to a higher incidence of chronic pain conditions such as arthritis, back pain, and joint pain among elderly individuals.

Pain Relief Patches Market

Pain relief patches provide a drug-free alternative that minimizes systemic exposure and adverse reactions. Advanced patches are designed to deliver active ingredients gradually over an extended period, ensuring sustained pain relief without frequent reapplication. Increasing participation in sports and fitness activities contributes to muscle strains, sprains, and sports-related injuries, driving demand for patches for acute pain relief and muscle recovery. Improving access to healthcare services and pain management therapies, including over-the-counter (OTC) patches, supports market expansion across diverse demographic groups.

Some individuals may experience skin irritation or allergic reactions to the adhesive or active ingredients in pain relief patches. This can lead to discomfort, reduced adherence to treatment, and potential discontinuation of product use. Pain relief patches are classified as medical devices or over-the-counter drugs in many jurisdictions. Compliance with diverse regulatory requirements for safety, efficacy, and quality assurance can be complex and costly for manufacturers.

Pain Relief Patches Market Trends

As populations age globally, the prevalence of chronic conditions such as arthritis and back pain is increasing. Pain relief patches offer a convenient and effective solution for managing persistent pain without the side effects associated with oral medications. Advances in transdermal drug delivery systems enhance the penetration of active ingredients through the skin, improving the efficacy and duration of pain relief. Consumers increasingly prefer non-invasive treatments that minimize systemic side effects. Pain relief patches offer localized therapy directly to the affected area, enhancing patient comfort and compliance.

Pain Relief Patches Market Analysis

Pain Relief Patches Market Size, By Type, 2021 - 2032 (USD Billion)

Based on type, the market is divided into prescription patches and over-the-counter patches. The prescription patches segment held the dominant market of USD 2.7 billion in 2023 and is expected to reach USD 4.8 billion by 2032. Prescription patches are often prescribed for managing severe or chronic pain conditions, such as osteoarthritis, fibromyalgia, or post-surgical pain, where stronger medications or continuous relief are required.

Healthcare providers prescribe prescription patches based on patient evaluations, medical history, and the need for controlled delivery of potent pain-relieving medications. OTC patches are readily accessible without a prescription, allowing consumers to manage mild to moderate pain symptoms conveniently at home or on-the-go.

Pain Relief Patches Market Revenue Share, By Application, (2023)

Based on application, the pain relief patches market is categorized into muscle pain, joint pain, sports injuries, back pain, minor aches and pains. The muscle pain application held the dominant market share of 41% in 2023. Athletes and fitness enthusiasts use muscle pain relief patches to alleviate soreness, strains, and overuse injuries, supporting recovery and maintaining peak performance. Patches offer localized delivery of active ingredients directly to affected muscle areas, providing targeted pain relief without systemic side effects associated with oral medications.

U.S. Pain Relief Patches Market Size, 2021 - 2032 (USD Million)

North America pain relief patches market size dominated around USD 1 billion in 2023 and is expected to reach USD 1.8 billion by 2032. North America has a significant aging population, which is prone to chronic pain conditions such as arthritis, back pain, and joint pain. As individuals age, the demand for effective pain relief solutions, including patches, increases.

The market in U.S. is set to grow through a CAGR of 6.6% through the forecast time period. Extensive distribution networks through pharmacies, drugstores, supermarkets, and e-commerce platforms ensure broad market reach and accessibility of pain relief patches to consumers across the U.S.

The German pain relief patches market maintained a considerable position in Europe. Urban living and sedentary work environments contribute to musculoskeletal discomfort and minor aches, prompting consumers to seek convenient and effective pain relief solutions like patches.

China is supposed to grow at the highest rate of 7.3% in the region. Increasing participation in sports, fitness activities, and outdoor recreation among urban populations contribute to higher incidences of sports-related injuries, muscle soreness, and joint pain. This drives demand for pain relief patches among athletes and active individuals.

Pain Relief Patches Market Share

Pain Relief Patches Market Share Analysis, 2023

Pain relief patches industry seem to be consolidated in nature due to presence of local and global players across the globe. In 2023, the market players such as Hisamitsu Pharmaceutical Co., Inc., Mylan N.V., GlaxoSmithKline plc, Johnson & Johnson, Sanofi, Novartis AG, Pfizer Inc. and Teva Pharmaceutical Industries Ltd. collectively held around 10%-15% market share. These prominent players are proactively involved in strategic endeavors, such as mergers & acquisitions, facility expansions & collaborations, to expand their product portfolios, extend their reach to a broader customer base, and strengthen their market position.

Pain Relief Patches Market Companies

Major players operating in the pain relief patches industry are:

  • 3M Health Care
  • Actavis
  • BioElectronics Corporation
  • Chattem, Inc.
  • Endo International plc
  • GlaxoSmithKline plc
  • Hisamitsu Pharmaceutical Co., Inc.
  • Johnson & Johnson
  • Mylan N.V.
  • Novartis AG
  • Pfizer Inc.
  • Reckitt Benckiser Group plc
  • Salonpas
  • Sanofi
  • Teva Pharmaceutical Industries Ltd.

Pain Relief Patches Industry News

  • In July 2023, Industrial Macchine Automatiche S.P.A. (Italy) acquired Phoenix Italia S.r.l. (Milano). IMA completed the acquisition of 60% of Phoenix Italia S.r.l. and 100% of its subsidiary Phoenix Tech S.r.l., both companies based in Bareggio (Milano), from its sole shareholder Phoenix Group Holding S.r.l.
  • In July 2023, IMA completed the purchase of 70% of Mespic S.r.l. and 100% of its Illinois-based subsidiary, Mespic North America Corporation, from its sole shareholder, Holding FGLG S.r.l.

The pain relief patches Market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue (USD Million) (Thousand Units) from 2021 to 2032, for the following segments:

Click here to Buy Section of this Report

Market, By Type

  • Prescription Patches
  • Over-the-counter Patches

Market, By Application

  • Muscle Pain
  • Joint Pain
  • Sports Injuries
  • Back Pain
  • Minor aches and pains

Market, By Pack Size

  • 1 Patch
  • 2-5 Patches
  • 5-10 Patches
  • More than 10 Patches

Market, By Price Range

  • Low
  • Mid
  • High

Market, By End-use

  • Individual
  • Commercial

Market, By Distribution Channel

  • Online
  • Offline

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Rest of Asia Pacific 
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • MEA
    • UAE
    • Saudi Arabia
    • South Africa
    • Rest of MEA


Authors: Avinash Singh, Sunita Singh

Frequently Asked Questions (FAQ) :

The market size of pain relief patches reached USD 3.9 billion in 2023 and will witness 6.2% CAGR between 2024 and 2032, propelled by the rising prevalence of chronic pain conditions, including arthritis and back pain, and increasing awareness of non-invasive pain management solutions.

The muscle pain application segment achieved 41% of the pain relief patches industry share in 2023 due to the widespread prevalence of muscle pain from physical activity, sports injuries, and aging.

North America market will record USD 1.8 billion by 2032, owing to the advanced technological capabilities and significant investment in R&D, high prevalence of chronic pain conditions and the strong healthcare infrastructure.

Some of the leading industry players include 3M Health Care, Actavis, Chattem, Inc., Endo International plc, GlaxoSmithKline plc, Hisamitsu Pharmaceutical Co., Inc., Johnson & Johnson, Mylan N.V., Novartis AG, Pfizer Inc., Reckitt Benckiser Group plc, Salonpas, Sanofi, and Teva Pharmaceutical Industries Ltd. among others.

Pain Relief Patches Market Scope

Buy Now

Premium Report Details

  • Base Year: 2023
  • Companies covered: 15
  • Tables & Figures: 428
  • Countries covered: 22
  • Pages: 487
 Download Free Sample